Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000277.3:c.184del

CA16020737

Gene: PAH (HGNC:5053)

Condition: phenylketonuria (MONDO:0009861)

Inheritance Mode: Autosomal recessive inheritance

UUID: 6ce4710c-a4cc-4862-bb59-65b80cf308c0

Approved on: 2019-04-04

Published on: 2019-08-16

HGVS expressions

NM_000277.3:c.184del

NC_000012.12:g.102894904del

CM000674.2:g.102894904del

NC_000012.11:g.103288682del

CM000674.1:g.103288682del

NC_000012.10:g.101812812del

NG_008690.1:g.27700del

NG_008690.2:g.68508del

NM_000277.1:c.184del

NM_000277.2:c.184del

NM_001354304.1:c.184del

ENST00000307000.7:c.169del

ENST00000546844.1:c.184del

ENST00000548677.2:n.271del

ENST00000548928.1:n.106del

ENST00000549111.5:n.280del

ENST00000550978.6:n.168del

ENST00000551337.5:c.184del

ENST00000551988.5:n.273del

ENST00000553106.5:c.184del

ENST00000635500.1:n.152del

Pathogenic

PP4 PM2 PM3 PVS1

Evidence Links 2

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.184delC variant in PAH has been previously reported as a heterozygous single variant in one Italian proband with mild HPA (PMID: 17096675) and in trans with the known pathogenic p.A403V allele in an Italian proband (PMID: 18346471). Of note, the two papers share the primary authors, so it is unclear whether this represents one versus two distinct patients. The variant is a 1bp deletion leading to a nonsense variant which occurs in exon 3 of 13 in the in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1). It is absent from control databases including ethnically matched individuals, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PM3, PP4.

PP4

c.184delC was detected in 1 Mild HPA patient. BH4 deficiency not assessed. PMID: 17096675

We studied 126 HPA patients, identified from neonatal screening, Phe serum concentration was measured. The patients were divided into three groups: classic PKU (or HPA I) when Phe >1200 μM (>20 mg/dL); mild PKU (HPA II) when Phe was between 600 and 1200 μM (10-20 mg/dL); and mild HPA (or HPA III) when Phe was between 120 and 600 μM (2–10 mg/dL). c.184delC was detected in 0.7% of Mild HPA patients. PubMed:17096675

PM2

It is absent from control databases including ethnically matched individuals, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2).

PM3

Detected in trans with the known pathogenic p.A403V allele in an Italian proband (PMID: 18346471).

PubMed:18346471

PVS1

The variant is a 1bp deletion leading to a nonsense variant which occurs in exon 3 of 13 in the in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1).

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.